Latest & greatest articles for heart failure

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on heart failure or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on heart failure and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for heart failure

41. Heart failure

Heart failure Top results for heart failure - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for heart failure The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

42. Factors associated with hospital emergency readmission and mortality rates in patients with heart failure or chronic obstructive pulmonary disease: a national observational study

Factors associated with hospital emergency readmission and mortality rates in patients with heart failure or chronic obstructive pulmonary disease: a national observational study Factors associated with hospital emergency readmission and mortality rates in patients with heart failure or chronic obstructive pulmonary disease: a national observational study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry (...) - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} Factors predicting mortality and readmission following admission with heart failure or chronic obstructive pulmonary disease were identified at both patient and hospital levels. {{author}} {{($index , , , & . Alex Bottle 1, * , Kate Honeyford 1 , Faiza

NIHR HTA programme2018

43. Sex differences in outcomes of heart failure in an ambulatory, population-based cohort from 2009 to 2013

Sex differences in outcomes of heart failure in an ambulatory, population-based cohort from 2009 to 2013 30012800 2018 07 22 1488-2329 190 28 2018 Jul 16 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Sex differences in outcomes of heart failure in an ambulatory, population-based cohort from 2009 to 2013. E848-E854 10.1503/cmaj.180177 Heart failure remains a substantial cause of morbidity and mortality in women. We examined the sex differences (...) in heart failure incidence, mortality and hospital admission in a population-based cohort. All Ontario residents who were diagnosed with heart failure in an ambulatory setting between Apr. 1, 2009, and Mar. 31, 2014, were included in this study. Incident cases of heart failure were captured through physician billing using a validated algorithm. Outcomes were mortality and hospital admission for heart failure within 1 year of the diagnosis. Probability of death and hospital admission were calculated

EvidenceUpdates2018 Full Text: Link to full Text with Trip Pro

44. Haemodynamic effects of percutaneous mitral valve edge‐to‐edge repair in patients with end‐stage heart failure awaiting heart transplantation

Haemodynamic effects of percutaneous mitral valve edge‐to‐edge repair in patients with end‐stage heart failure awaiting heart transplantation 30058757 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Haemodynamic effects of percutaneous mitral valve edge-to-edge repair in patients with end-stage heart failure awaiting heart transplantation. 892-901 10.1002/ehf2.12313 Functional mitral regurgitation is complicating end-stage heart failure and potential heart (...) transplantation by increasing pulmonary artery pressures. The aim of the present study was to investigate feasibility and haemodynamic effects of percutaneous mitral valve edge-to-edge repair using the MitraClip™ device in patients with end-stage heart failure awaiting heart transplantation. In this retrospective study, we identified nine patients suffering from end-stage heart failure listed for heart transplantation in whom moderate-severe or severe functional mitral regurgitation was recognized and treated

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

45. Effect of the self-management education program on the quality of life in people with chronic heart failure: a randomized controlled trial

Effect of the self-management education program on the quality of life in people with chronic heart failure: a randomized controlled trial 30128093 2018 11 14 2008-5842 10 7 2018 Jul Electronic physician Electron Physician Effect of the self-management education program on the quality of life in people with chronic heart failure: a randomized controlled trial. 7028-7037 10.19082/7028 Chronic Heart Failure (CHF) is a syndrome that negatively affects a person's Quality of Life (QOL (...) ). The efficient self-management education program increases the individual's abilities and skills for following and participating in a long-term healthcare plan. The aim of this study was to determine the effect of the self-management education program on QOL in people with CHF. This randomized controlled trial study was conducted on 60 people with CHF and without sensory-cognitive problem from April-August 2015. They were selected using the convenience sampling method, and were randomly assigned

Electronic physician2018 Full Text: Link to full Text with Trip Pro

46. Sacubitril–valsartan in heart failure and multimorbidity patients

Sacubitril–valsartan in heart failure and multimorbidity patients 30039930 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Sacubitril-valsartan in heart failure and multimorbidity patients. 956-959 10.1002/ehf2.12338 The poor control of symptoms in patients with advanced heart failure with reduced ejection function (HFrEF) can limit the functionality of patients. Sacubitril-valsartan, compared with enalapril, has been shown to reduce mortality and hospitalization (...) , and nowadays, there is still little evidence about the improvement on functionality. The aim of our study is to analyse the improvement of the functional class and the 6 min walking test (6MWT) in patients with multiple pathologies and advanced heart failure. From September 2016 to March 2018, 65 multimorbidity patients with severe symptomatic HFrEF were initiated to receive sacubitril-valsartan. Mean age was 78.6 ± 7.4 years, and 68% were male. The Charlson co-morbidity index was 8 points. Seventy-four

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

47. Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues

Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues 30030912 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues. 755-763 10.1002/ehf2.12316 Pulmonary hypertension (PH) is a common and severe complication of heart failure (HF). Consequently, HF is the leading cause of PH. For many years, specialists have attempted to better understand (...) the pathophysiology of PH in HF, to define its prevalence and its impact on prognosis in order to improve the therapeutic management of these patients. Nowadays, despite the recent guidelines published on the subject, several points remain unclear or debated, and until now, no study has demonstrated the efficacy of any treatment. The aim of this review is to report the evolution of the concepts on post-capillary PH (diagnosis, prevalence, prognosis, and therapeutics). The main issues are raised, focusing

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

48. Diagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterization

Diagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterization 30015395 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Diagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterization. 902-910 10.1002/ehf2.12317 Pulmonary congestion remains a diagnostic challenge in patients with heart failure (HF). The recommended method, chest X-ray (CXR), lacks (...) in accuracy, whereas quantitative tomographic lung scintigraphy [ventilation/perfusion single-photon emission computed tomography (V/P SPECT)] has shown promising results but needs independent validation. The aim of this study is to evaluate V/P SPECT as a non-invasive method to assess and quantify pulmonary congestion in HF patients, using right heart catheterization as reference method. The secondary objective was to investigate the performance of V/P SPECT in the clinical setting compared with CXR

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

49. Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment

Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment 30015405 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. 800-808 10.1002/ehf2.12331 Left atrium (LA) dilation is associated with adverse cardiovascular (CV) outcomes. Blood stasis, thrombus formation and atrial fibrillation may occur, especially in heart failure (...) (HF) patients. It is not known whether preventive antithrombotic treatment may decrease the incidence of CV events in HF patients with LA enlargement. We investigated the relationship between LA enlargement and CV outcomes in HF patients and the effect of different antithrombotic treatments. Two-dimensional echocardiography with LA volume index (LAVi) measurement was performed in 1148 patients with systolic HF from the Warfarin versus Aspirin in Reduced Ejection Fraction (WARCEF) trial. Patients

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

50. Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure

Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure 30062098 2018 11 14 2297-055X 5 2018 Frontiers in cardiovascular medicine Front Cardiovasc Med Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure. 95 10.3389/fcvm.2018.00095 Schmitz Boris B Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, University Hospital Muenster, Muenster, Germany. Brand Stefan (...) -Martin SM Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, University Hospital Muenster, Muenster, Germany. eng Journal Article Comment 2018 07 16 Switzerland Front Cardiovasc Med 101653388 2297-055X Hypertension. 2018 Feb;71(2):280-288 29255073 cardiac hypertrophy exercise heart failure micoRNAs remodeling 2018 06 11 2018 06 28 2018 8 1 6 0 2018 8 1 6 0 2018 8 1 6 1 epublish 30062098 10.3389/fcvm.2018.00095 PMC6054969 J Mol Cell Cardiol. 2007 Jun;42(6):1137-41 17498736

Frontiers in cardiovascular medicine2018 Full Text: Link to full Text with Trip Pro

51. Identifying cut‐off scores for interpretation of the Heart Failure Impact Questionnaire

Identifying cut‐off scores for interpretation of the Heart Failure Impact Questionnaire 30338103 2018 11 14 2054-1058 5 4 2018 Oct Nursing open Nurs Open Identifying cut-off scores for interpretation of the Heart Failure Impact Questionnaire. 575-582 10.1002/nop2.168 Heart failure (HF) influences health-related quality of life. However, the factors that contribute to health-related quality of life remain unclear in Taiwan. We aim to identify the factors influencing health-related quality (...) of life in HF patients. Hospitalized HF ( N = 225) patients were included from April 2011 to April 2014. Health-related quality of life was assessed by using the 36-Item Short-Form Health Survey (SF-36) and the Minnesota Living with Heart Failure Questionnaire. A new cut-off was conducted based on the combination of SF-36 and Minnesota Living with Heart Failure questionnaire. There were significant differences between good and poor quality groups on age, gender, education levels, occupational classification

Nursing open2018 Full Text: Link to full Text with Trip Pro

52. Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) trial

Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) trial 29984912 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial. 965-976 10.1002/ehf2.12315 In patients with heart failure and a pathologically prolonged PR interval, left ventricular (LV) filling can be improved by shortening atrioventricular delay (...) using His-bundle pacing. His-bundle pacing delivers physiological ventricular activation and has been shown to improve acute haemodynamic function in this group of patients. In the HOPE-HF (His Optimized Pacing Evaluated for Heart Failure) trial, we are investigating whether these acute haemodynamic improvements translate into improvements in exercise capacity and heart failure symptoms. This multicentre, double-blind, randomized, crossover study aims to randomize 160 patients with PR prolongation

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

53. Low frequency electrical muscle stimulation and endothelial function in advanced heart failure patients

Low frequency electrical muscle stimulation and endothelial function in advanced heart failure patients 29971969 2018 11 14 2055-5822 5 4 2018 08 ESC heart failure ESC Heart Fail Low frequency electrical muscle stimulation and endothelial function in advanced heart failure patients. 727-731 10.1002/ehf2.12293 Obtain initial estimates of the change in brachial artery endothelial function and maximal oxygen uptake (VO 2peak ) with 8 weeks of low-frequency electrical muscle stimulation (LF-EMS (...) ) or sham in patients with advanced chronic heart failure. Using a double blind, randomized design, 35 patients with chronic heart failure (New York Heart Association class III-IV) were assigned to 8 weeks (5 × 60 min per week) of either LF-EMS (4 Hz, continuous) or sham (skin level stimulation only) of the quadriceps and hamstrings muscles. Four of the five sessions were at home and one under supervision. Ultrasound images of resting brachial artery diameter and post 5 min occlusion to determine flow

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

54. Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure

Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure 29969536 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure. 911-919 10.1002/ehf2.12319 The arginine vasopressin (AVP) pathway has been extensively studied (...) in heart failure (HF) with reduced ejection fraction (HFrEF), but less is known about AVP in HF with preserved EF (HFpEF). Furthermore, the association between AVP and atrial natriuretic peptide (ANP, a well-known inhibitor of AVP secretion) in HF is unknown. We studied subjects with HFpEF (n = 28) and HFrEF (n = 25) and without HF (n = 71). Left ventricular (LV) mass and left atrial (LA) volumes were measured with cardiac magnetic resonance imaging. Arginine vasopressin and ANP were measured

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

55. Heart failure

Heart failure Autosynthesis - Trip Database or use your Google+ account Find evidence fast My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button

Trip Evidence Maps2018

56. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. BACKGROUND: Beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve survival and reduce morbidity in people with heart failure with reduced left ventricular ejection fraction. There is uncertainty whether these treatments are beneficial for people with heart failure with preserved ejection fraction and a comprehensive review (...) of the evidence is required. OBJECTIVES: To assess the effects of beta-blockers, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, angiotensin receptor neprilysin inhibitors, and mineralocorticoid receptor antagonists in people with heart failure with preserved ejection fraction. SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase and two clinical trial registries on 25 July 2017 to identify eligible studies. Reference lists from primary studies and review articles were checked

Cochrane2018

57. A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care

A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care 29943902 2018 12 12 2055-5822 5 4 2018 08 ESC heart failure ESC Heart Fail A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care. 703-712 10.1002/ehf2.12302 Primary care physicians lack access to an objective cardiac function test. This study for the first time describes a novel cardiac output (...) response to stress (CORS) test developed to improve diagnosis and monitoring of heart failure in primary care and investigates its reproducibility. Prospective observational study recruited 32 consecutive primary care patients (age, 63 ± 9 years; female, n = 18). Cardiac output was measured continuously using the bioreactance method in supine and standing positions and during two 3 min stages of a step-exercise protocol (10 and 15 steps per minute) using a 15 cm height bench. The CORS test

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

58. Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure

Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure 29938922 2018 11 14 2055-5822 5 4 2018 08 ESC heart failure ESC Heart Fail Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. 668-674 10.1002/ehf2.12297 Recent guidelines recommend cardiac resynchronization therapy (CRT) in mildly symptomatic heart failure (HF) but favour left bundle branch block (LBBB) morphology in patients with moderate QRS prolongation (...) (120-150 ms). We defined how many patients hospitalized with HF fulfil these criteria. A single-centre retrospective cohort study of 363 consecutive patients hospitalized with HF (438 admissions) was performed. Electronic imaging, electrocardiograms, and records were reviewed. Overall, 153 patients (42%) had left ventricular ejection fraction (LVEF) ≤ 35%, and 34% of patients had QRS prolongation. Eighty patients (22%) were potentially eligible with LVEF ≤ 35% and QRS ≥ 120 ms or existing CRT

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

59. Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE‐HF study

Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE‐HF study 29934976 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE-HF study. 809-817 10.1002/ehf2.12309 The primary aim of the TRIAGE-HF trial was to correlate cardiac implantable electronic device-generated heart failure risk status (HFRS) with signs, symptoms (...) , and patient behaviours classically associated with worsening heart failure (HF). TRIAGE-HF enrolled 100 subjects with systolic HF implanted with a Medtronic high-performance device and followed up at three Canadian HF centres. Study follow-up was up to 8 months. The HFRS assigned each subject's overall risk of HF hospitalization in the next 30 days and also highlighted abnormal device parameters contributing to a patient's risk status at the time of remote data transmission. Subjects with a high HFRS were

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

60. Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence

Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence 29932314 2018 11 29 2055-5822 5 5 2018 10 ESC heart failure ESC Heart Fail Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence. 931-947 10.1002/ehf2.12305 Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Effective treatment strategies (...) to stabilize AHF are important to alleviate clinical symptoms and to improve clinical outcomes. However, despite the progress in the management of stable and chronic heart failure, no single agent has been proven to play a definitive role in the management of AHF. As a consequence, contemporary treatment strategies for patients with AHF vary greatly by region. This manuscript reviews the medical treatment options for AHF, with an emphasis on the differences between the treatment strategies in the USA

ESC heart failure2018 Full Text: Link to full Text with Trip Pro